Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway

被引:24
作者
Greuter, Marjolein J. E. [1 ]
Demirel, Erhan [1 ]
Lew, Jie-Bin [2 ,3 ]
Berkhof, Johannes [1 ]
Xu, Xiang-Ming [2 ,3 ]
Canfell, Karen [2 ,3 ]
Dekker, Evelien [4 ]
Meijer, Gerrit A. [5 ]
Coupe, Veerle M. H. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, POB 7057,MF F Wing, NL-1007 MB Amsterdam, Netherlands
[2] Univ NSW, Lowy Canc Res Ctr, Sydney, NSW, Australia
[3] Univ NSW, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia
[4] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
RANDOMIZED CONTROLLED-TRIAL; OCCULT BLOOD-TESTS; HYPERPLASTIC POLYPS; IMMUNOCHEMICAL TEST; COLON; COLONOSCOPY; ADENOMA; CLASSIFICATION; POPULATION; ROUNDS;
D O I
10.1158/1055-9965.EPI-15-0592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to predict the long-term colorectal cancer incidence, mortality, and colonoscopy demand of the recently implemented Dutch colorectal cancer screening program. Methods: The Adenoma and Serrated pathway to Colorectal Cancer model was set up to simulate the Dutch screening program consisting of biennial fecal immunochemical testing combined with the new Dutch surveillance guidelines, between 2014 and 2044. The impact of screening and surveillance was evaluated under three sets of natural history assumptions differing in the contribution of the serrated pathway to colorectal cancer incidence. In sensitivity analyses, other assumptions concerning the serrated pathway were varied. Model-predicted outcomes were yearly colorectal cancer incidence, mortality, and colonoscopy demand per year. Results: Assuming an aging population, colorectal cancer incidence under 30 years of screening is predicted to decrease by 35% and 31% for a contribution of 0% and 30% of the serrated pathway to colorectal cancer, respectively. For colorectal cancer mortality, reductions are 47% and 45%. In 2044, 110,000 colonoscopies will be required annually assuming no contribution of the serrated pathway (27 per 1,000 individuals in the screening age range). Including the serrated pathway influences predicted screening effectiveness if serrated lesions are neither detected nor treated at colonoscopy, and/or if colorectal cancers arising from serrated lesions have substantially lower survival rates than those arising from adenomas. Conclusions: The Dutch screening program will markedly decrease colorectal cancer incidence and mortality but considerable colonoscopy resources will be required. Impact: Predictions of long-term screening effectiveness are preferably based on both pathways to colorectal cancer to transparently describe the impact of uncertainties regarding the serrated pathway on long-term predictions. (C) 2015 AACR.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 51 条
  • [1] Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist
    Abdeljawad, Khaled
    Vemulapalli, Krishna C.
    Kahi, Charles J.
    Cummings, Oscar W.
    Snover, Dale C.
    Rex, Douglas K.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2015, 81 (03) : 517 - 524
  • [2] The serrated pathway to colorectal carcinoma: current concepts and challenges
    Bettington, Mark
    Walker, Neal
    Clouston, Andrew
    Brown, Ian
    Leggett, Barbara
    Whitehall, Vicki
    [J]. HISTOPATHOLOGY, 2013, 62 (03) : 367 - 386
  • [3] Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269 000 cases
    Bokemeyer, Bernd
    Bock, Herbert
    Hueppe, Dietrich
    Dueffelmeyer, Marc
    Rambow, Axel
    Tacke, Wolfgang
    Koop, Herbert
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (06) : 650 - 655
  • [4] Colonoscopic screening of an average-risk population for colorectal neoplasia
    Boursi, B.
    Halak, A.
    Umansky, M.
    Galzan, L.
    Guzner-Gur, H.
    Arber, N.
    [J]. ENDOSCOPY, 2009, 41 (06) : 516 - 521
  • [5] Sessile Serrated Adenomas and Their Pit Patterns: We Must First See the Forest Through the Trees
    Burke, Carol A.
    Snover, Dale C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (03) : 470 - 472
  • [6] High Rate of Advanced Adenoma Detection in 4 Rounds of Colorectal Cancer Screening With the Fecal Immunochemical Test
    Crotta, Sergio
    Segnan, Nereo
    Paganin, Simona
    Dagnes, Bruna
    Rosset, Roberto
    Senore, Carlo
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (06) : 633 - 638
  • [7] Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
    De Sousa E Melo, Felipe
    Wang, Xin
    Jansen, Marnix
    Fessler, Evelyn
    Trinh, Anne
    de Rooij, Laura P. M. H.
    de Jong, Joan H.
    de Boer, Onno J.
    van Leersum, Ronald
    Bijlsma, Maarten F.
    Rodermond, Hans
    van der Heijden, Maartje
    van Noesel, Carel J. M.
    Tuynman, Jurriaan B.
    Dekker, Evelien
    Markowetz, Florian
    Medema, Jan Paul
    Vermeulen, Louis
    [J]. NATURE MEDICINE, 2013, 19 (05) : 614 - 618
  • [8] Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia
    de Wijkerslooth, T. R.
    Stoop, E. M.
    Bossuyt, P. M.
    Meijer, G. A.
    van Ballegooijen, M.
    van Roon, A. H. C.
    Stegeman, I.
    Kraaijenhagen, R. A.
    Fockens, P.
    van Leerdam, M. E.
    Dekker, E.
    Kuipers, E. J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (10) : 1570 - 1578
  • [9] Sporadic and syndromic hyperplastic polyps & serrated adenomas of the colon: Classification, molecular genetics, natural history, and clinical management
    East, James E.
    Saunders, Brian P.
    Jass, Jeremy R.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2008, 37 (01) : 25 - +
  • [10] Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study
    Faivre, J
    Dancourt, V
    Lejeune, C
    Tazi, MA
    Lamour, J
    Gerard, D
    Dassonville, F
    Bonithon-Kopp, C
    [J]. GASTROENTEROLOGY, 2004, 126 (07) : 1674 - 1680